A method for overcoming antibiotic resistance uses multimodal nanoparticles that target bacterial defence mechanisms while enhancing the innate immune response. The rise in antibiotic resistance is considered a slow-moving medical catastrophe, as these revolutionary drugs that have kept us relatively safe from bacterial infection for decades are losing their efficacy. In part due to their co-evolution, bacterial pathogens have developed mechanisms to resist almost every antibiotic on the market and we are in desperate need for new, innovative approaches. Writing in Nature Nanotechnology, Zhu et al. present a nanoparticle-based possibility, in which they target bacterial defence mechanisms while simultaneously enhancing the ability of the host immune cells to fight infection.
All Posts
Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease.
PubMed ID: 38625674 Author(s): Maganti N, Whittier SA, Warner EJ. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease. J Ophthalmic Inflamm Infect. 2024 Apr 16;14(1):15. …
Fluorimetric detection of DNA methylation by cerium oxide nanoparticles for early cancer diagnosis.
PubMed ID: 38586346 Author(s): Adampourezare M, Nikzad B, Amini M, Sheibani N. Fluorimetric detection of DNA methylation by cerium oxide nanoparticles for early cancer diagnosis. Heliyon. 2024 Mar 23;10(7):e28695. doi: 10.1016/j.heliyon.2024.e28695. eCollection 2024 Apr 15. …
Ophthalmology Alumni Association Welcomes New Members
The UW Department of Ophthalmology and Visual Sciences is pleased to welcome three new members to the UW Ophthalmology Alumni Association.
Introducing the 2024 Kambara Symposium Keynote Speaker: Budd Tucker, PhD
A highly accomplished vision scientist and expert in retinal disease will be the keynote speaker at the 2023 George Kambara, MD Vision Science Symposium on Friday, April 14, 2024.
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion.
PubMed ID: 38061584 Author(s): Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA; SCORE2 Investigator Group. Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central …
Solar Eclipse Eye Safety Tips
On April 8, the entire United States will experience a partial eclipse of the sun. The UW—Madison Department of Ophthalmology and Visual Sciences has important guidelines to protect your eyes and stay safe.
Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes.
PubMed ID: 38559222 Author(s): Liu TYA, Huang J, Channa R, Wolf R, Dong Y, Liang M, Wang J, Abramoff M. Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes. Res Sq …
New Vision Research Utilizes “Cell” Sequencing to Shed Light on Childhood Glaucoma
Stuart Tompson, PhD and colleagues at the University of Wisconsin—Madison are exploring a novel cell profiling approach to understand Primary Congenital Glaucoma (PCG). PCG is a severe pediatric eye disease affecting 1 in 10,000 infants …